Armed With The Truth • United We Stand

Latest

Study | 84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months

Study | 84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months

PaulCraigRoberts.org Epidemiologist Nicolas Hulscher breaks down the findings: Nicolas Hulscher | GlobalResearch.ca 84.4% of the cancer patients taking ivermectin + mebendazole reported no evidence of disease, tumor regression, or cancer stabilization after 6 months. Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer PatientsReal-World Clinical Outcomes of Ivermectin and
TRUTH11.COM
© Truth11.com 2026